Skip to main content
. 2014 Jan 22;9(1):e86316. doi: 10.1371/journal.pone.0086316

Figure 1. Kaplan-Meier analysis for patients with isoniazid (INH)-resistant tuberculosis (TB) remaining on treatment.

Figure 1

Patients with low-concentration INH-monoresistant TB (dashed line) and high-concentration INH-monoresistant TB (solid line) received a similar duration of anti-TB therapy (p = 0.761 by the log-rank test, hazard ratio = 1.06, 95% confidence interval, 0.73–1.55).